sur SPINEGUARD (EPA:ALSGD)
SpineGuard obtains European validation for its patent in orthopedic surgery
SpineGuard, a company specializing in digital surgical guidance, announced that the European Patent Office has validated its patent for automatic bone gap detection. This patent protects algorithms used during bone drilling operations, designed to make orthopedic procedures safer and simpler.
Stéphane Bette, Deputy CEO of SpineGuard, emphasizes the importance of this patent, which strengthens strategic discussions with the industry, particularly for applications in motorized and robotic equipment. SpineGuard, with a robust intellectual property portfolio of 72 patents, continues to expand its DSG technology to smart surgical tools.
Developed in partnership with research institutes such as the CNRS, this patent marks an important step for the company, which already has a previous validation in the United States. SpineGuard hopes to confirm its position in the international market for advanced medical technologies.
R. P.
Copyright © 2025 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de SPINEGUARD